ASCENDIS
LIVE

Serial Number

88884168

Owner

Ascendis Pharma A/S

Attorney

Shannon Marie McKeon

Filing Date

Apr 23, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ASCENDIS Trademark

Serial Number: 88884168 • Registration: 7033396

ASCENDIS is a trademark filed by Ascendis Pharma A/S on April 23, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment). The application is currently registered and active.

Owner Contact Info

Ascendis Pharma A/S (9 trademarks)

Tuborg Boulevard 5
Hellerup 2900 , DK

Entity Type: 16

Trademark Details

Filing Date

April 23, 2020

Registration Date

April 25, 2023

Published for Opposition

February 7, 2023

Goods & Services

Educational and teaching services, namely, training sessions and providing classes, workshops, and seminars in the field of pharmaceutical, medical, and health care topics; Arranging and conducting of conferences, including speaker programs, symposiums, seminars, workshops, lectures and online education seminars and guides about pharmaceutical, medical and healthcare topics; Editorial reporting services; News syndication reporting; Non-downloadable electronic publications in the nature of ad boards, magazines, journals and articles in the field of pharmaceutical, medical and healthcare topics

Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to physical and mental diseases fur use by patients and health care professional; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history

Pharmaceutical and medical preparations for the treatment of physical and mental diseases; Pharmaceutical and medical preparations for the treatment of growth disorders, endocrine disorders, bone disorders, cancer and infectious diseases; Diagnostic preparations for medicinal use; Diagnostic preparations for identification and proof of physical and mental diseases; Diagnostic preparations for identifying and detecting growth hormone disorders, endocrine disorders, bone disorders and cancer and infectious diseases; Dietetic preparations for medical use, sanitary preparations for medical use, dietetic preparations adapted for medical use, food supplements; Medicated shampoos, soaps, lotions for skin, face and body and dentifrices; Disinfectants; Fungicides, herbicides

Medical devices for injection, dosage and control of pharmaceuticals; Syringes for injection for medical and surgical use, namely, syringes in the form of pens for surgical use digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with the treatment of physical and mental diseases; Medical apparatus, namely, infusion and injection devices for administering drugs; Medicine dosage dispensers containing recorded software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; medicine dosage management dispensers containing recorded software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 25, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 25, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 7, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 18, 2023 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 3, 2023 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 27, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 27, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 27, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 27, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 27, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 26, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 26, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 26, 2022 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 14, 2022 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 6, 2022 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 18, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 15, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 15, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 15, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 14, 2022 GNFN
FINAL REFUSAL E-MAILED
Jul 14, 2022 GNFR
FINAL REFUSAL WRITTEN
Jul 14, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 1, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 1, 2022 CRFA
ASSIGNED TO LIE
Mar 31, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 29, 2022 ERSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 2, 2021 RCCK
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 2, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 2, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 2, 2021 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 27, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 27, 2021 GNSL
SUSPENSION LETTER WRITTEN
Apr 27, 2021 CNSL
ASSIGNED TO EXAMINER
Mar 12, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 25, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 23, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 23, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jul 23, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 16, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 4, 2020 NWOS
NEW APPLICATION ENTERED
Apr 27, 2020 NWAP